前收市價 | 7.34 |
開市 | 7.27 |
買盤 | 7.31 x 100 |
賣出價 | 7.39 x 200 |
今日波幅 | 7.23 - 7.64 |
52 週波幅 | 1.63 - 8.83 |
成交量 | |
平均成交量 | 2,933,270 |
市值 | 835.167M |
Beta 值 (5 年,每月) | 1.67 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.64 |
業績公佈日 | 2024年5月01日 - 2024年5月06日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 7.80 |
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2023 Earnings Call Transcript February 26, 2024 Fate Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.45, expectations were $-0.57. Fate Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Fate […]